News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
PERCEPTIVE ADVISORS LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 0% stake in Neptune Wellness Solutions Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 0% stake in Research Alliance Corp. II |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 9.3% stake in Rain Oncology Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 12.3% stake in Verrica Pharmaceuticals Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 7.6% stake in Inhibrx, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 3.8% stake in Mirati Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 3.6% stake in Concert Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 2.6% stake in Prometheus Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 9.2% stake in Amylyx Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 4.9% stake in Tarsus Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 10% stake in IsoPlexis Corporation |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 14.4% stake in Acrivon Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 0.4% stake in IVERIC bio, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 19.4% stake in Aldeyra Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 6.3% stake in Iovance Biotherapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 7.1% stake in Bellus Health Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 7.2% stake in Zymeworks Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 9.9% stake in enVVeno Medical Corporation |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 9.8% stake in Amicus Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 5.3% stake in RAPT Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 5.4% stake in ADMA Biologics, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 0% stake in Agile Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 8.5% stake in Albireo Pharma, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 4.2% stake in SpringWorks Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 0% stake in Coherus BioSciences, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 6.8% stake in Leap Therapeutics, Inc. |
| 11/03/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 9.8% stake in SpringWorks Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 15.8% stake in Quotient Limited |
| 02/14/2022 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 4.8% stake in BridgeBio Pharma, Inc. |
| 02/14/2022 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 0% stake in Collegium Pharmaceutical, Inc. |
| 02/14/2022 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 6.6% stake in Zymeworks Inc.. |
| 02/14/2022 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 6.1% stake in ADMA Biologics, Inc. |
| 02/14/2022 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 4.5% stake in VYNE Therapeutics, Inc. |
|
|
|